JP2022502369A5 - - Google Patents
Info
- Publication number
- JP2022502369A5 JP2022502369A5 JP2021516452A JP2021516452A JP2022502369A5 JP 2022502369 A5 JP2022502369 A5 JP 2022502369A5 JP 2021516452 A JP2021516452 A JP 2021516452A JP 2021516452 A JP2021516452 A JP 2021516452A JP 2022502369 A5 JP2022502369 A5 JP 2022502369A5
- Authority
- JP
- Japan
- Prior art keywords
- cdr
- sequence
- seq
- amino acid
- acid sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862742408P | 2018-10-07 | 2018-10-07 | |
| US62/742,408 | 2018-10-07 | ||
| US201862780599P | 2018-12-17 | 2018-12-17 | |
| US62/780,599 | 2018-12-17 | ||
| US201962820701P | 2019-03-19 | 2019-03-19 | |
| US62/820,701 | 2019-03-19 | ||
| US201962864060P | 2019-06-20 | 2019-06-20 | |
| US62/864,060 | 2019-06-20 | ||
| PCT/CA2019/051434 WO2020073121A1 (en) | 2018-10-07 | 2019-10-07 | Conformation-specific epitopes in alpha-synuclein, antibodies thereto and methods related thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022502369A JP2022502369A (ja) | 2022-01-11 |
| JP2022502369A5 true JP2022502369A5 (cg-RX-API-DMAC7.html) | 2022-10-20 |
| JP7719713B2 JP7719713B2 (ja) | 2025-08-06 |
Family
ID=70163645
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021516452A Active JP7719713B2 (ja) | 2018-10-07 | 2019-10-07 | α－シヌクレインの立体配座特異的エピトープ、それに対する抗体、およびそれに関連する方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US12404321B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3861015A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP7719713B2 (cg-RX-API-DMAC7.html) |
| AU (1) | AU2019356804B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3148562A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2020073121A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7136790B2 (ja) | 2017-02-17 | 2022-09-13 | ブリストル－マイヤーズ スクイブ カンパニー | アルファ－シヌクレインに対する抗体およびその使用 |
| WO2025236075A1 (en) * | 2024-05-07 | 2025-11-20 | The University Of British Columbia | Immunogenic compositions for synucleinopathies |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7358331B2 (en) * | 2003-05-19 | 2008-04-15 | Elan Pharmaceuticals, Inc. | Truncated fragments of alpha-synuclein in Lewy body disease |
| AT506535B1 (de) * | 2008-02-22 | 2010-04-15 | Affiris Forschungs & Entwicklungs Gmbh | Vaccine enthaltend alpha-synuclein-mimotope auf basis von peptiden |
| US9045555B2 (en) | 2008-07-01 | 2015-06-02 | De Staat Der Nederlanden, Vert. Door De Minister Van Vws | Vaccine against amyloid folding intermediate |
| CN102348720A (zh) * | 2009-03-09 | 2012-02-08 | 雷蒙特亚特特拉维夫大学有限公司 | 预防和治疗神经退行性疾病的组合物和方法 |
| CN102596236B (zh) * | 2009-07-30 | 2015-06-24 | 辉瑞疫苗有限责任公司 | 抗原性Tau肽及其用途 |
| EP2542571B1 (en) * | 2010-03-03 | 2016-05-25 | The University of British Columbia | Oligomer-specific amyloid beta epitope and antibodies |
| CN102504016B (zh) * | 2011-12-08 | 2014-05-28 | 清华大学 | 淀粉样蛋白纤维性寡聚体构象型抗原表位多肽及其应用 |
| US9534044B2 (en) | 2013-02-28 | 2017-01-03 | United Arab Emirates University | Alpha-synuclein antibodies and uses thereof |
| EP3374380A4 (en) | 2015-11-09 | 2019-05-15 | The University Of British Columbia | C-terminal epitopes in amyloid-beta and conformation-sensitive antibodies |
| EP3448874A4 (en) | 2016-04-29 | 2020-04-22 | Voyager Therapeutics, Inc. | COMPOSITIONS FOR TREATING A DISEASE |
| KR102550991B1 (ko) | 2016-07-18 | 2023-07-04 | 더 유니버시티 오브 브리티쉬 콜롬비아 | 아밀로이드 베타에 대한 항체 |
| US10364286B2 (en) * | 2016-12-22 | 2019-07-30 | H. Lundbeck A/S | Monoclonal anti-alpha-synuclein antibodies for preventing tau aggregation |
-
2019
- 2019-10-07 JP JP2021516452A patent/JP7719713B2/ja active Active
- 2019-10-07 US US17/283,292 patent/US12404321B2/en active Active
- 2019-10-07 AU AU2019356804A patent/AU2019356804B2/en active Active
- 2019-10-07 WO PCT/CA2019/051434 patent/WO2020073121A1/en not_active Ceased
- 2019-10-07 CA CA3148562A patent/CA3148562A1/en active Pending
- 2019-10-07 EP EP19870641.8A patent/EP3861015A4/en active Pending
-
2025
- 2025-05-23 US US19/217,829 patent/US20250346655A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7607498B2 (ja) | 成長分化因子１５（ｇｄｆ－１５）に対するモノクローナル抗体およびがん悪液質およびがんを処置するためのその使用 | |
| JP2020522475A5 (cg-RX-API-DMAC7.html) | ||
| US20200347130A1 (en) | CD96 Antibody, Antigen-Binding Fragment and Pharmaceutical use Thereof | |
| EP1881064B1 (en) | HCV-Anti-core monoclonal antibody | |
| JP2020500508A5 (cg-RX-API-DMAC7.html) | ||
| JP2019505166A5 (cg-RX-API-DMAC7.html) | ||
| JP2019504615A5 (cg-RX-API-DMAC7.html) | ||
| US20220340674A1 (en) | Method for the production of bispecific fcyriii x cd30 antibody construct | |
| US12559548B2 (en) | Antibodies to misfolded TDP-43 and methods of use | |
| CN117624358B (zh) | Aβ1-40特异性抗体及其在阿尔茨海默症辅助诊断试剂盒的应用 | |
| CN113227148B (zh) | 抗gpc3抗体、其抗原结合片段及其医药用途 | |
| CN110461874B (zh) | 抗gitr抗体、其抗原结合片段及其医药用途 | |
| JP2025146838A5 (cg-RX-API-DMAC7.html) | ||
| CN113993534A (zh) | 针对iRhom2的蛋白结合物 | |
| EP3596464A2 (en) | Target detection using a monovalent antibody | |
| CN117820473B (zh) | Aβ1-42特异性抗体及其在阿尔茨海默症辅助诊断试剂盒的应用 | |
| CN109678950B (zh) | spink1抗原、能够特异性结合spink1的抗体及其功能片段及其应用和产品 | |
| CN111741974B (zh) | 单离抗硫酸吲哚酚的单株抗体及/或其抗原结合片段的组成物及其使用 | |
| JP2024542944A5 (cg-RX-API-DMAC7.html) | ||
| CN115298216A (zh) | 抗体或其抗原结合片段、其制备方法及医药用途 | |
| JP2019513004A5 (cg-RX-API-DMAC7.html) | ||
| JP5683466B2 (ja) | 抗ｐｓｋ抗体 | |
| WO2025086564A1 (zh) | 抗人vsig4的抗体及其医药用途 | |
| JP2955082B2 (ja) | ヒトカルシトニンのｎ末端部分を特異的に認識するモノクローナル抗体 | |
| EP2762494A2 (en) | Monoclonal antibodies against scrapie prion protein (PrPSc), and the use thereof |